Nektar Therapeutics | NKTR - 営業経費





営業経費 変化する 日付
Agios Pharmaceuticals USD 130.77M 10.77M 2026-03
ALKERMES USD 1.75B 1.43B 2026-03
Alterity Therapeutics Limited AUD 8.67M 893.38K 2025-12
Amgen USD 4.78B 1.12B 2026-03
Baxter International USD 6.04B 2.85B 2026-03
BioCryst Pharmaceuticals USD -553.84M 700.01M 2026-03
Biogen USD 1.96B 69.6M 2026-03
Bristol-Myers Squibb USD 20.07B 11.77B 2026-03
Cara Therapeutics USD 5.94M 983K 2025-09
Cipla INR 59.27B 1.71B 2026-03
Dr.Reddys Laboratories INR 74.58B 977M 2026-03
Eisai JPY 215.74B 15.84B 2026-03
Eli Lilly USD 10.02B 285M 2026-03
Esperion Therapeutics USD 83.21M 14.06M 2025-12
Exelixis USD 359.47M 3.28M 2026-03
Gilead Sciences USD 23.52B 18.55B 2026-03
GlaxoSmithKline GBP 5.34B 1.85B 2026-03
Grifols EUR 1.99B 217.4M 2025-12
Halozyme Therapeutics USD 192.19M 18.88M 2026-03
Incyte USD 5.62B 4.5B 2026-03
Ionis Pharmaceuticals USD 364M 54M 2026-03
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 51.92M 9.9M 2025-12
MacroGenics USD 21.2M 32.13M 2026-03
Merck USD 18.17B 8.01B 2026-03
Nektar Therapeutics USD 40.9M 44.19M 2025-12
Neurocrine Biosciences USD 599.9M 22.3M 2026-03
Novartis USD 9.29B 507M 2026-03
Pfizer USD 90.1B 77.19B 2026-03
Roche Holding CHF 21.01B 10.84B 2025-12
Sarepta Therapeutics USD 372.37M 480.65M 2026-03
Takeda JPY 1.11T 85.29B 2026-03
Teva Pharmaceutical Industries USD 3.22B 1000M 2026-03
Xencor USD 82.38M 513K 2026-03